• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马蒂斯痴呆评定量表的结构与鉴别力分析

Analysis of structure and discriminative power of the Mattis Dementia Rating Scale.

作者信息

Hofer S M, Piccinin A M, Hershey D

机构信息

University of Southern California, USA.

出版信息

J Clin Psychol. 1996 Jul;52(4):395-409. doi: 10.1002/(SICI)1097-4679(199607)52:4<395::AID-JCLP4>3.0.CO;2-P.

DOI:10.1002/(SICI)1097-4679(199607)52:4<395::AID-JCLP4>3.0.CO;2-P
PMID:8842876
Abstract

The study examines the factor structure and provides test of the discriminative properties of the 38-item Mattis Dementia Rating Scale (MDRS). The MDRS was designed a priori to measure five broad domains of cognitive abilities: attention, initiation/perseveration, conceptualization, construction, and memory. Complete item level data were collected at the USC Alzheimer Disease Research Center from 19 probable Alzheimer's Disease (AD) patients, 17 cases with dementia of various etiologies (e.g., multiple infarct), and 49 contrast subjects. Factor analyses, with rotation to equamax criterion, were performed on education partialled data. Five and six factor solutions accounted for most of the reliable variance and permitted simple structure theoretical description for separate subscales. These factors, similar to Mattis' design, can be characterized as Memory (Recall)/Verbal Fluency, Construction, Memory (short-term), Initiation/Perseveration, and Simple Commands. Cross-validated discriminant analyses performed on five unit-weighted composite variables derived from factor analysis provided better classification (72% vs 62%) than the 38 Mattis items alone.

摘要

该研究考察了38项马蒂斯痴呆评定量表(MDRS)的因子结构并对其区分性特征进行了检验。MDRS在设计之初旨在测量认知能力的五个广泛领域:注意力、启动/持续、概念化、构图和记忆。完整的项目级数据是在美国南加州大学阿尔茨海默病研究中心收集的,来自19名可能患有阿尔茨海默病(AD)的患者、17名患有各种病因(如多发性梗死)痴呆的病例以及49名对照对象。对剔除教育因素的数据进行了采用等量最大旋转标准的因子分析。五因素和六因素解决方案解释了大部分可靠方差,并允许对各个子量表进行简单结构的理论描述。这些因子与马蒂斯的设计类似,可被描述为记忆(回忆)/语言流畅性、构图、记忆(短期)、启动/持续和简单指令。对从因子分析得出的五个单位加权复合变量进行的交叉验证判别分析提供了比单独使用38个马蒂斯项目更好的分类(72%对62%)。

相似文献

1
Analysis of structure and discriminative power of the Mattis Dementia Rating Scale.马蒂斯痴呆评定量表的结构与鉴别力分析
J Clin Psychol. 1996 Jul;52(4):395-409. doi: 10.1002/(SICI)1097-4679(199607)52:4<395::AID-JCLP4>3.0.CO;2-P.
2
Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.用于帕金森病痴呆筛查的马蒂斯痴呆评定量表的临界值。
Mov Disord. 2008 Aug 15;23(11):1546-50. doi: 10.1002/mds.22173.
3
[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].[简短认知功能测试组合(B2C)的验证。在精神科实践中筛查阿尔茨海默病和抑郁症的价值]
Encephale. 2003 May-Jun;29(3 Pt 1):266-72.
4
Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study.
Drugs Exp Clin Res. 2004;30(1):27-33.
5
Subscale validity of the Mattis Dementia Rating Scale.马蒂斯痴呆评定量表的分量表效度
Arch Clin Neuropsychol. 1997;12(3):269-75.
6
Screening of dementia in stroke patients with lacunar infarcts: comparison of the mattis dementia rating scale and the mini-mental state examination.腔隙性脑梗死中风患者的痴呆筛查:马蒂斯痴呆评定量表与简易精神状态检查表的比较
J Geriatr Psychiatry Neurol. 2005 Mar;18(1):3-7. doi: 10.1177/0891988704269814.
7
The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
Int J Neurosci. 2006 May;116(5):613-27. doi: 10.1080/00207450600592164.
8
Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.认知和行为特征可区分阿尔茨海默病和帕金森病。
Neuropsychiatry Neuropsychol Behav Neurol. 2002 Jun;15(2):79-87.
9
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].[一种用于评估精神分裂症认知功能的新工具的价值:精神分裂症认知功能简短评估量表(BACS)]
Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9.
10
[Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].[用于痴呆诊断以及区分阿尔茨海默病和额颞叶痴呆的阿登布鲁克认知检查西班牙文版的效度]
Rev Neurol. 2005;41(12):717-21.

引用本文的文献

1
The diagnostic accuracy of dementia-screening instruments with an administration time of 10 to 45 minutes for use in secondary care: a systematic review.10 至 45 分钟内完成的用于二级保健的痴呆筛查工具的诊断准确性:系统评价。
Am J Alzheimers Dis Other Demen. 2010 Jun;25(4):301-16. doi: 10.1177/1533317510367485.
2
Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.马蒂斯痴呆评定量表评估卡巴拉汀治疗帕金森病痴呆疗效的效用
J Neurol. 2006 Sep;253(9):1154-9. doi: 10.1007/s00415-006-0175-2. Epub 2006 Sep 22.
3
Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
帕金森病痴呆和路易体痴呆患者在痴呆评定量表上的表现:与进行性核上性麻痹和阿尔茨海默病的比较。
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1215-20. doi: 10.1136/jnnp.74.9.1215.